Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII
Tarfah Al‐Warhi, Mostafa M. Elbadawi, Alessandro Bonardi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2635-2643
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations
Ahmed A. Al‐Karmalawy, Mohamed S. Nafie, Moataz A. Shaldam, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 777-792
Closed Access | Times Cited: 41
1,5-Diaryl-1,2,4-triazole Ureas as New SLC-0111 Analogues Endowed with Dual Carbonic Anhydrase and VEGFR-2 Inhibitory Activities
Ahmed E. Elsawi, Mostafa M. Elbadawi, Alessio Nocentini, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10558-10578
Closed Access | Times Cited: 28
4-(5-Amino-pyrazol-1-yl)benzenesulfonamide derivatives as novel multi-target anti-inflammatory agents endowed with inhibitory activity against COX-2, 5-LOX and carbonic anhydrase: Design, synthesis, and biological assessments
Mahmoud A. Ragab, Wagdy M. Eldehna, Alessio Nocentini, et al.
European Journal of Medicinal Chemistry (2023) Vol. 250, pp. 115180-115180
Closed Access | Times Cited: 25
Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological evaluations, andin silicostudies
Samia M. Al-Muntaser, Ahmed A. Al‐Karmalawy, Abeer M. El‐Naggar, et al.
RSC Advances (2023) Vol. 13, Iss. 18, pp. 12184-12203
Open Access | Times Cited: 25
2-Aminobenzothiazoles in anticancer drug design and discovery
G. Huang, Tomasz Cierpicki, Jolanta Grembecka
Bioorganic Chemistry (2023) Vol. 135, pp. 106477-106477
Closed Access | Times Cited: 24
The potential of carbonic anhydrase enzymes as a novel target for anti-cancer treatment
Xiaoqun Zhou, Xian‐Li Ma, Nur Syamimi Ariffin
European Journal of Pharmacology (2024) Vol. 976, pp. 176677-176677
Closed Access | Times Cited: 6
Exploring genetic associations and drug targets for mitochondrial proteins and schizophrenia risk
Wenxi Sun, Ping Sun, Jin Li, et al.
Schizophrenia (2025) Vol. 11, Iss. 1
Open Access
Development of pyrazolo[1,5-a]pyrimidine-grafted coumarins as selective carbonic anhydrase inhibitors and tubulin polymerization inhibitors with potent anticancer activity
Mahmoud S. Elkotamy, Mohamed A. Abdelrahman, Simone Giovannuzzi, et al.
International Journal of Biological Macromolecules (2025), pp. 140462-140462
Closed Access
Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFR WT and EGFR T790M inhibitors
Tarfah Al‐Warhi, Ahmed A. Al‐Karmalawy, Ayman Abo Elmaaty, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 176-191
Open Access | Times Cited: 26
Discovery of indolinone-bearing benzenesulfonamides as new dual carbonic anhydrase and VEGFR-2 inhibitors possessing anticancer and pro-apoptotic properties
Samaa Saied, Moataz A. Shaldam, Mostafa M. Elbadawi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115707-115707
Closed Access | Times Cited: 19
SLC-0111, an inhibitor of carbonic anhydrase IX, attenuates hepatoblastoma cell viability and migration
Katja Eloranta, Marjut Pihlajoki, Emmi Liljeström, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer
Wagdy M. Eldehna, Eslam Essam Mohammed, Ghada H. Al-Ansary, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115538-115538
Closed Access | Times Cited: 16
Targeting carbonic anhydrases for the management of hypoxic metastatic tumors
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 11, pp. 701-720
Closed Access | Times Cited: 16
Deciphering the Lexicon of Protein Targets: A Review on Multifaceted Drug Discovery in the Era of Artificial Intelligence
Suvendu Nandi, Soumyadeep Bhaduri, Debraj Das, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 4, pp. 1563-1590
Closed Access | Times Cited: 5
Novel sulfonamide-tethered Schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: Synthesis, biological assessment, and molecular dynamic simulations
Moataz A. Shaldam, Maha-Hamadien Abdulla, Andrea Angeli, et al.
Journal of Molecular Structure (2024) Vol. 1309, pp. 138148-138148
Closed Access | Times Cited: 5
Therapeutic Potential of Natural Metabolites Coupled Pyrazole and Its Bio‐Isosteres: Medicinal Perspectives and SAR Studies
Bhupender Nehra, Manoj Kumar, Pooja A. Chawla, et al.
ChemistrySelect (2024) Vol. 9, Iss. 13
Closed Access | Times Cited: 4
Synthesis of novel bioactive pyrido[2,3-d]pyrimidine derivatives with potent cytotoxicity through apoptosis as PIM-1 kinase inhibitors
Eman S. Tantawy, Mohamed S. Nafie, Hesham A. Morsy, et al.
RSC Advances (2024) Vol. 14, Iss. 16, pp. 11098-11111
Open Access | Times Cited: 4
Atropo/Tropo Flexibility: A Tool for Design and Synthesis of Self-Adaptable Inhibitors of Carbonic Anhydrases and Their Antiproliferative Effect
Jekaterīna Ivanova, Alessio Nocentini, Kaspars Tārs, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 8, pp. 5703-5718
Closed Access | Times Cited: 10
Investigation of novel alkyl/benzyl (4-sulphamoylphenyl)carbamimidothioates as carbonic anhydrase inhibitors
Morteza Abdoli, Alessandro Bonardi, Claudiu T. Supuran, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 9
Design and synthesis of novel quinazolinone–chalcone hybrids as potential apoptotic candidates targeting caspase-3 and PARP-1:in vitro, molecular docking, and SAR studies
Eman A. Madbouly, El‐Sayed M. Lashine, Ahmed A. Al‐Karmalawy, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 46, pp. 22013-22029
Closed Access | Times Cited: 17
Development of novel anilinoquinazoline-based carboxylic acids as non-classical carbonic anhydrase IX and XII inhibitors
Zainab M. Elsayed, Hadia Almahli, Alessio Nocentini, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 9
Recent development of azole–sulfonamide hybrids with the anticancer potential
Chenyuan Zhao, Liu Yang, Zhuo Cui
Future Medicinal Chemistry (2024) Vol. 16, Iss. 12, pp. 1267-1281
Closed Access | Times Cited: 2
Synthesis, biological evaluation and in silico studies of novel thiadiazole-hydrazone derivatives for carbonic anhydrase inhibitory and anticancer activities
Hayrani Eren Bostancı, Ulviye Acar Çevik, Ravikumar Kapavarapu, et al.
SAR and QSAR in environmental research (2023) Vol. 34, Iss. 7, pp. 543-567
Open Access | Times Cited: 7
Computational Design, Synthesis, and Bioevaluation of 2-(Pyrimidin-4-yl)oxazole-4-carboxamide Derivatives: Dual Inhibition of EGFRWT and EGFRT790M with ADMET Profiling
Nilesh Raghunath Khedkar, Milind Sindkhedkar, Alex Joseph
Bioorganic Chemistry (2023) Vol. 143, pp. 107027-107027
Closed Access | Times Cited: 6
In‐vitro and in‐silico investigations of SLC‐0111 hydrazinyl analogs as human carbonic anhydrase I, II, IX, and XII inhibitors
Vikas Sharma, Lalit Vats, Simone Giovannuzzi, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 8
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top